Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer - Drug Trials For Money - Paid Clinical Trials

Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer

Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer
Conditions:   SBRT;   Borderline Resectable Pancreatic Cancer;   Unresectable Pancreatic Cancer
Interventions:   Drug: Drug GC4711;   Drug: Placebo
Sponsor:   Galera Therapeutics, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 30, 2022 / by / in
Comments